India at a Glance
  Advantage India
  Economy
  Investment
  Trade
  States & UTs
  Industry & Services
  Doing Business
  Studies & Surveys
  Visitor's Guide
 
 
ECONOMY

PHARMACEUTICALS

Pfizer Inc

Pfizer Inc is the world's largest research-based biomedical and pharmaceutical company. Founded in 1849, it is dedicated to better health and greater access to health care for people and their valued animals. Its corporate headquarters are in New York, with major research and development locations in the United States and England.

Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Limited (India) is one of the fastest growing pharmaceutical companies in India. Globally one of the highest spenders in pharmaceutical R&D, Pfizer has made clinical research investments of US $ 15.75 million in India. A survey has ranked Pfizer as the most respected MNC pharmaceutical company.

For more information, visit:www.pfizer.com

Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programmes that not only donate Merck medicines but also help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.

MSD Pharmaceuticals Private Limited is an affiliate of Merck & Co. Inc., USA. With global headquarter in New Jersey, USA, Merck & Co. Inc. The Merck Manufacturing Division employs more than 12,000 people at locations in 25 countries.

For more information, visit: www.merck.com

Wockhardt Limited

Wockhardt is a global, pharmaceutical and biotechnology company that has grown by leveraging two powerful trends impacting the world of medicine-globalisation and biotechnology.

The company has a market capitalisation of over US$ 1 billion and an annual turnover of US$ 650 million.

The company has its headquarters in India, and has 14 manufacturing plants in India, UK, Ireland, France and US; subsidiaries in US, UK, Ireland and France and marketing offices in Africa, Russia, Central and South East Asia.

Wockhardt's strategies are aligned towards being a significant player in the emerging global biopharmaceuticals market. In order to achieve this goal, the company has set up the Wockhardt biotech park, India's largest biopharmaceuticals complex, with six dedicated plants built to international standards.

For more information, visit: www.wockhardtin.com

Cadila Pharmaceuticals Ltd

Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the state of Gujarat. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world. An integrated healthcare solutions provider with pharmaceutical product basket, it caters to over 50 therapeutic areas. The company focuses on providing high quality, appropriately priced products to its customers and supports all these with dedicated customer service. Cadila Pharmaceuticals has a workforce of more than 4000 employees including over 200 people outside India in forty-nine countries of Africa, CIS, Japan and USA.

The company has one of the best research and development (R&D) setups in India, manned by more than three hundred and fifty scientists and engineers from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, phytochemistry and different disciplines of engineering. The company also participates in public-private partnerships for developing diagnostic, preventive and curative pharmaceutical and diagnostic products.

Cadila Pharmaceuticals is the first Indian company to get investigational new drug (IND) approval by USFDA for clinical trials to be conducted in India. Subsequently, the company has filed four more INDs with USFDA.

For more information, visit:www.cadilapharma.com

Ranbaxy

Ranbaxy was incorporated in 1961 and went public in 1973.Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide.

Ranbaxy has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe with a presence in 23 of the Top 25 pharma markets of the world. Additionally the Company has a presence in 21 of the 25 EU countries. Ranbaxy has robust operations in USA, UK, France, Germany, Russia, India, Brazil and South Africa, and is strengthening its business in Japan, Italy, Spain and several other markets in the Asia Pacific.

For more information

Dr Reddy's Labs

Dr. Reddy's Laboratories was founded by Dr Anji Reddy, a entrepreneur-scientist, in 1984 . Today, the company is India’s second largest pharmaceutical company and the youngest among its peer group.

The company has several distinctions to its credit. Being the first pharmaceutical company from Asia Pacific (outside Japan) to be listed on the New York Stock Exchange (on April 11, 2001) is only one among them.

Dr. Reddy's continues its journey, leveraging on its 'Low Cost, High Intellect' advantage. It has been constantly foraying into new markets and new businesses and taking on new challenges and growing stronger and more capable.

For more information

Cadila

Cadila is one of India’s most reputed, Research based, Tech savvy pharmaceutical company, focusing on areas – Formulations (Human & Veterinary), New Drug Discovery, Novel Drug Delivery, Active Pharmaceutical Ingredients, Analytical Research, Phytochemistry, Biotechnology, Plant Tissue Culture, Biosynthesis, Genetic Engineering, Vaccines, Immunoglobulins – the entire gamut of a True Life Sciences Company.The company's diversified operations encompass Hospital Disposables & Instrumentation, Diagnostics, Specialty Chemicals, Softgel, Pharma Machinery, Telecommunications, Travel & Leisure.

Cadila Pharmaceuticals is fast emerging as a true Indian multinational.The company has their wholly owned subsidiaries, joint ventures, strategic alliances, contract manufacturing, own marketing offices in 4 countries and have significant presence in over 46 countries across the globe. Their business revolves around the exports of formulations, bulk actives, hospital disposables, veterinary formulations and pharmaceutical machinery manufacturing.

Besides a significant presence in the Americas, CIS Countries, Africa, Central and South-East Asia, Oceanic Countries, Japan, Middle East and Europe, the company has offices in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan and Ukraine. The International SBU plans to expand operations to more than 100 countries by 2010.

For more information

 

 


 


 
 
Home
About India in Business
Business Events
Business News
Contact Us
   
   
  India at a Glance
  Advantage India
  Economy
  Investment
  Trade
   
   
  States & UTs
  Industry & Services
  Doing Business
  Studies & Surveys
  Visitor Guide
     
     
Best viewed in 1024 x 800 pxl Disclaimer